Alliances between pharmaceutical companies can take a number of forms to accommodate the strategic interests of the partnering firms. These alliances also occur at different stages in the product lifecycle, from early stage product development, to late stage development to the sales and marketing of an approved product, and even occur once a product is approaching or reaches patent expiry. CRA’s Life Sciences Practice has been asked to assess the value of different types of marketing alliances.
Supply chain management in the AI era: A vision statement from the operations management community
CRA’s Maxime Cohen is a contributor to the academic and industry leader team releasing the vision statement “Supply Chain Management in the AI era: A Vision...